This, alongside the previous discussion about ENHO’s immunomodulatory role, is a plausible explanation for why increased ENHO expression is associated with better overall survival in pancreatic adenocarcinoma patients. The gene discussed is ENHO; the disease is pancreatic adenocarcinoma.